Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial

OBJECTIVE: To test the hypothesis that ticagrelor plus aspirin is safe and superior to clopidogrel plus aspirin for reducing high platelet reactivity at 90 days and stroke recurrence in patients with minor stroke or transient ischaemic attack, particularly in carriers of the CYP2C19 loss-of-function...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ
Main Authors: Wang, Yilong, Chen, Weiqi, Lin, Yi, Meng, Xia, Chen, Guohua, Wang, Zhimin, Wu, Jialing, Wang, Dali, Li, Jianhua, Cao, Yibin, Xu, Yuming, Zhang, Guohua, Li, Xiaobo, Pan, Yuesong, Li, Hao, Zhao, Xingquan, Liu, Liping, Lin, Jinxi, Dong, Kehui, Jing, Jing, Johnston, S Claiborne, Wang, David, Wang, Yongjun
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group Ltd. 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6549283/
https://ncbi.nlm.nih.gov/pubmed/31171523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.l2211
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados